Product
Daxibotulinumtonix A
1 clinical trial
2 indications
Indication
MigraineIndication
headacheClinical trial
A Multi-Center Unblinded Proof-of-Concept Study of DaxibotulinumtoxinA for Migraine Prevention in High-Frequency and Chronic Migraine: the Standard ParadigmStatus: Recruiting, Estimated PCD: 2024-09-01